Phenotypical and genetic analysis of human immunodeficiency virus (HIV-1) and subtype B isolated in Russia

被引:0
|
作者
Selimova, LM [1 ]
Bobkov, AF
Serebrovskaya, LV
Kravchenko, AV
Lyubaeva, YV
Kazennova, YV
Sankov, MN
Pokrovsky, VV
机构
[1] DI Ivanovskii Virol Inst, Moscow 123098, Russia
[2] Russian Sci Educ AIDS Prevent Ctr, Moscow, Russia
关键词
type I human immunodeficiency virus; subtype B; isolate; phenotype; genotype; characteristics;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency type 1 virus env subtype B 95RU25B isolated from a Russian citizen is studied. The time course of clinical changes and immunological parameters over 5.5 years is presented. Phenotypical characteristics of the isolate were assessed by culturing in different sensitive cell cultures. Genotyping by the heteroduplex analysis and env gene sequencing were carried out. 95RU25B variant is capable of infecting a wide spectrum of cell cultures and by the type of replication can be classified with the S/L.3 group. The phenotypical properties of the isolate apparently determine the characteristic features in the primary structure of V3 loop.
引用
收藏
页码:110 / 113
页数:4
相关论文
共 50 条
  • [21] Human Immunodeficiency Virus Type 1 (HIV-1) Subtype B Epidemic in Panama Is Mainly Driven by Dissemination of Country-Specific Clades
    Mendoza, Yaxelis
    Martinez, Alexander A.
    Castillo Mewa, Juan
    Gonzalez, Claudia
    Garcia-Morales, Claudia
    Avila-Rios, Santiago
    Reyes-Teran, Gustavo
    Armien, Blas
    Pascale, Juan M.
    Bello, Gonzalo
    PLOS ONE, 2014, 9 (04):
  • [22] STIMULATORY EFFECTS OF THE HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) ON LYMPHOCYTE-B DIFFERENTIATION
    CHIRMULE, N
    KALYANARAMAN, VS
    SAXINGER, C
    PAHWA, SG
    CLINICAL RESEARCH, 1988, 36 (03): : A437 - A437
  • [23] EXERCISE AND HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) INFECTION
    LAWLESS, D
    JACKSON, CGR
    GREENLEAF, JE
    SPORTS MEDICINE, 1995, 19 (04) : 235 - 239
  • [24] Vectors derived from the human immunodeficiency virus, HIV-1
    Barker, E
    Planelles, V
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 : D491 - D510
  • [25] CRYSTALLIZATION OF THE ASPARTYLPROTEASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS, HIV-1
    MCKEEVER, BM
    NAVIA, MA
    FITZGERALD, PMD
    SPRINGER, JP
    LEU, CT
    HEIMBACH, JC
    HERBER, WK
    SIGAL, IS
    DARKE, PL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (04) : 1919 - 1921
  • [26] THROMBOCYTOPENIA ASSOCIATED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1)
    CASTELLANO, AD
    RODRIGUEZ, JJV
    MEDICINA CLINICA, 1992, 98 (17): : 671 - 675
  • [27] THE NEPHROPATHOLOGY IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) INFECTION
    BOURGOIGNIE, JJ
    PARDO, V
    KIDNEY INTERNATIONAL, 1991, 40 : S19 - S23
  • [28] HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 (HIV-1) AND THE BRAIN
    GRANT, I
    HEATON, RK
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1990, 58 (01) : 22 - 30
  • [29] HYPOCHOLESTEROLEMIA AND HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) INFECTION
    DURSUN, SM
    REVELEY, MA
    AMERICAN JOURNAL OF MEDICINE, 1995, 98 (05): : 518 - 518
  • [30] The immune response to human immunodeficiency virus type 1 (HIV-1)
    Turnbull, E
    Borrow, P
    MOLECULAR PATHOGENESIS OF VIRUS INFECTIONS, 2005, 64 : 23 - 89